Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study
Clinical trial NCT03461211 · COMPLETED
Trial details
- NCT number
- NCT03461211
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2020-06-08
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.